Oncology firm posts 33% revenue increase

FORT MYERS — Revenues at 21st Century Oncology Holdings rose 33% to $269.5 million in the fourth quarter compared with the same quarter one year ago.

Meanwhile, the operator of 180 cancer-treatment centers posted a quarterly net loss of $22.7 million in the fourth quarter ending Dec. 31 compared with a net loss of $14.3 million in the same quarter one year ago as expenses rose.

“During 2014, we added a net of 123 new physicians,” says Daniel Dosoretz, the founder and CEO of 21st Century Oncology, in a statement. “Also during the year we added a net of 17 additional centers, 14 of which are domestic and 3 international. We entered 2015 with the same focus on executing our strategy of organic growth combined with prudently taking advantage of attractive strategic de-leveraging acquisitions and joint ventures in order to continue delivering integrated cancer care at academic quality and create compelling value for our steadily expanding patient population.”